Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Items 901–1,000 of 1,000

Anomalous expression of miR-103 in polycystic ovary syndrome influenced by hormonal, and metabolic variables
Mu, J., & Li, Q. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104482 · Cited by 7
Non-invasive evaluation of meibomian gland morphology and tear film and anterior segment parameters in women with polycystic ovarian syndrome
Yakut, B., & Gürlek, B. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102654 · Cited by 7
Electroacupuncture improves follicular development and metabolism and regulates the expression of adiponectin, AMPK and ACC in an obese rat model of polycystic ovary syndrome
Zhou, J., Yin, P., Zhao, Q., Hu, Z., Wang, Y., Ma, G., Wu, X., Lu, L., & Shi, Y. (2022) · Acupuncture in Medicine · doi:10.1177/09645284221107690 · Cited by 7
Tempol modulates lncRNA-miRNA-mRNA ceRNA networks in ovaries of DHEA induced PCOS rats
Li, T., Zhang, T., Gao, H., Wang, H., Yan, H., Wan, Z., Liu, R., & Yin, C. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106175 · Cited by 7
Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats
Yu, F., Xue, Y., Zhao, Y., Zhang, L., He, X., & Liu, Z. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2183045 · Cited by 8
Comparison of premenstrual symptoms, psychological well-being, and nutritional status between Palestinian women with and without polycystic ovarian syndrome: a case-control study
Almahareeq, M., Hamdan, M., Vanoh, D., Shawarb, N., Herbawi, J., Shawar, E., Al-wohoush, R., Mohtaseb, M., & Badrasawi, M. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03210-z · Cited by 10
Preliminary Detection of Cyst Formation in Ovary Using Advanced Computer Vision Approach
Ragit, N., Zanke, P., Jaipurkar, M., Agrawal, R., Gaurihar, M., & Dhule, C. (2024) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt61001.2024.10723845 · Cited by 7
Alterations in pituitary gland volume in polycystic ovary syndrome: a structural magnetic resonance imaging study
Ünlü, E., Ünlü, B. S., Turamanlar, O., Acay, M. B., Kaçar, E., Yıldız, Y., Verim, Ö., Okur, N., Balçık, Ç., Taşgetiren, S., et al. (2014) · Clinical Imaging · doi:10.1016/j.clinimag.2014.10.002 · Cited by 7
Induction of secretory leukocyte protease inhibitor (SLPI) in estradiol valerate (EV) induced polycystic ovary
Park, J. J., Bae, C. S., Choi, B., Jeong, S., Wang, G., Lim, D., Kim, B., Cho, Y., Kim, S.-J., & Jeong, M. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0820-x · Cited by 7
Elevated circulating levels of xenopsin-related peptide-1 are associated with polycystic ovary syndrome
Temür, M., Özbay, P. Ö., Aksun, S., Yılmaz, Ö., Çift, T., Üstünel, S., & Çalan, M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4493-7 · Cited by 7
Brain Diffusion Changes in Polycystic Ovary Syndrome
Ünlü, E., Duran, A., Balçık, Ç., Acay, M. B., Yıldız, Y., Tulmaç, Ö. B., Ünlü, B. S., & Yücel, A. (2017) · Canadian Association of Radiologists Journal · doi:10.1016/j.carj.2017.04.004 · Cited by 7
Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome
Rashad, N. M., Abd-Elrahman, M. N. A., El‐Shal, A. S., & Amin, A. I. (2018) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2018.04.008 · Cited by 7
Age‐related diagnostic threshold of anti‐Müllerian hormone for polycystic ovarian syndrome
Kakkad, V., Reddy, S., Nihlani, H., & Gundewar, T. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13515 · Cited by 7
Vitamin D Concentrations at Term Do Not Differ in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
Kollmann, M., Obermayer-Pietsch, B. M., Lerchbaum, E., Feigl, S., Hochstätter, R., Pregartner, G., Trummer, C., & Klaritsch, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030537 · Cited by 7
The “Hitchhiker’s Guide to the Galaxy” of Endothelial Dysfunction Markers in Human Fertility
Santi, D., Spaggiari, G., Greco, C., Lazzaretti, C., Paradiso, E., Casarini, L., Potì, F., Brigante, G., & Simoni, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052584 · Cited by 7
Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome
Zhang, Z., Sang, M., Liu, S., Shao, J., & Cai, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00829-6 · Cited by 7
Assessment of Clinical, Biochemical, and Hormonal Profile of Lean Versus Overweight Polycystic Ovarian Syndrome Patients
Ghatnatti, V., Patil, S., & Kour, H. (2022) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_117_20 · Cited by 7
Aberrant BMP15/HIF-1α/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development
Cao, L., Zhang, Z., Liu, P., Xu, D., Tang, L., Fan, L., Sun, X.-C., Li, J., Wu, Q., Li, Z.-M., et al. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2125951 · Cited by 7
The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome
Zhou, H., Xu, J., Hong, L., Jia, Y., Burk, L. V., Chi, F., Zhao, M., Guan, X., Liu, D., Yin, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1038184 · Cited by 8
A Comprehensive Review on Tailoring an Herbal Approach for Treatment of Poly Cystic Ovarian Syndrome
Purohit, A., Jain, S., Nema, P., Jain, D. K., Vishwakarma, H., & Jain, P. K. (2022) · Asian Journal of Dental and Health Sciences · doi:10.22270/ajdhs.v2i1.13 · Cited by 7
The impact of biological clock and sex hormones on the risk of disease
Furtado, A., Costa, D. R. B., Lemos, M. C., Cavaco, J. E. B., Santos, C. R. A., & Quintela, T. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.03.004 · Cited by 8
Pregnancy Rates in Women With Polycystic Ovary Syndrome (PCOS) Using Letrozole Versus Clomiphene Citrate: A Retrospective Record Review
Bahawi, Y. O., Radwan, E. M., Khouj, M. A., Alotaibi, R. K., Bajuwaiber, N. A., Baghlaf, L. F., AlFaraj, W. F., & Oraif, A. (2023) · Cureus · doi:10.7759/cureus.42257 · Cited by 8
Association of polycystic ovarian syndrome with human leukocyte antigen polymorphism in Korean women
Kim, J., Hwang, K. R., Shin, S., Yoon, J. H., Kim, B. J., Choi, Y. M., & Roh, E. Y. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02779.x · Cited by 7
Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS
Salehabadi, M., Farimani, M. S., Tavilani, H., Ghorbani, M., Poormonsefi, F., Poorolajal, J., Shafiee, G., Ghasemkhani, N., & Khodadadi, I. (2016) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2016.1143055 · Cited by 7
L’hormone anti-müllerienne
Catteau-Jonard, S., Dewailly, D., Prévot, V., Cimino, I., & Giacobini, P. (2016) · médecine/sciences · doi:10.1051/medsci/20163205005 · Cited by 7
Self-citation
The correlation between thyroid hormones, reproductive hormones, body mass index (BMI) and hirsute in Iraqi women with polycystic ovary syndrome (PCOS).
Al-Faisal, A. H. M., & Al-Deresawi, M. S. (2013) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2013.84922 · Cited by 7
Homeostasis Model Assessment-Insulin Resistance (HOMA-IR), a Key Role for Assessing the Ovulation Function in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance
Ma, F., Lin, Q., Yue, H., Shuxiang, X. I. E., Zhou, X., Jiang, M., Zhang, W., Qi, J., Wang, L., & Kehui, X. U. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-094 · Cited by 7
Efficacy of acupuncture on menstrual frequency in women with polycystic ovary syndrome
Zhou, J. W., Yang, L., Yu, J., Wang, Y., & Liu, Z. (2017) · Medicine · doi:10.1097/md.0000000000008828 · Cited by 7
Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome
Qin, L., Zhao, S., Yang, P., Cao, Y., Zhang, J., Chen, Z., Dunaif, A. E., & Zhao, H. (2020) · Endocrine · doi:10.1007/s12020-020-02538-4 · Cited by 7
Synchrony between Ovarian Function & Sleep in Polycystic Ovary Syndrome Patients
Zangeneh, F. Z., Naghizadeh, M. M., Abdollahi, A., & Bagheri, M. (2014) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2014.412101 · Cited by 7
Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients
Abu-Fakher, B., Al-Quobaili, F., & Alhalabi, M. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2012.12.005 · Cited by 7
Knowledge on female hygiene and its associated diseases: a mini review
Girigoswami, K., Girigoswami, A., Harini, A. L., & Jayaprakash, T. (2023) · Arab Gulf Journal of Scientific Research · doi:10.1108/agjsr-02-2023-0074 · Cited by 6
Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience
Benelli, E., Marradi, M., Sciarroni, E., Cosmo, C. D., Bagattini, B., Ghianda, S. D., Simoncini, T., Fruzzetti, F., Tonacchera, M., & Fiore, E. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02404-4 · Cited by 6
Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research
Yazdanpanah, Z., Cheraghi, E., Nasrabadi, M. H., & Salehipour, M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03745-w · Cited by 6
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome
Wu, H., Yang, M., Yan, C., Liu, M., Wang, H., & Zhang, W. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13230 · Cited by 6
The effects of ketogenic diet on metabolic and hormonal parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials
Eshaghhosseiny, N., Ahmadi, M., Izadi, B., Vali, M., Akbari, M., Azari, I., & Akbari, H. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01441-3 · Cited by 10
Enhancing PCOS Prediction Accuracy Through Machine Learning Optimization
Sharma, K., Kumar, R., Verma, R., Kaur, A., Shah, S. K., & Hussien, M. (2024) · International Conference on Data Science and Network Security (ICDSNS) · doi:10.1109/icdsns62112.2024.10690877 · Cited by 6
Association of Prooxidant–Antioxidant Balance with Clinical and Laboratory Parameters and Its Relation to Different Drug Regimens in Polycystic Ovary Syndrome Women with Normal BMI
Heshmati, N., Shahgheibi, S., Nikkhoo, B., Amini, S., & Abdi, M. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0613-6 · Cited by 6
Endocrine disruption induced by bisphenol A in young and adult female Sprague Dawley rats
Hamdy, H., Yahia, D., Afifi, S. H., & Salem, D. A. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2689-2 · Cited by 6
Influence of obesity on soluble endoglin and transforming growth factor β1 in women with polycystic ovary syndrome
Rashad, N. M., Amin, A. I., Ali, A. E., & Soliman, M. H. (2018) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2018.07.003 · Cited by 6
Efficacy of a Herbal Formulation Based on Foeniculum Vulgare in Oligo/Amenorrhea: A Randomized Clinical Trial
Falahat, F., Ayatiafin, S., Jarahi, L., Mokaberinejad, R., Rakhshandeh, H., Feyzabadi, Z., & Tavakkoli-Kakhki, M. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666181029120512 · Cited by 7
Association between the vascular endothelial growth factor gene polymorphisms and the risk of polycystic ovary syndrome in Northern Chinese women
Huang, X., Hao, Y., Zhen, X., Zhou, R., Wang, N., Cao, S.-R., & Li, Y. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1579789 · Cited by 6
Performance Analysıs of Polycystıc Ovary Syndrome (PCOS) Detectıon System Usıng Neural Network Approach
Boomidevi, R., & Usha, S. (2021) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-16-0081-4_47 · Cited by 6
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
Zhang, J., Tang, L., Kong, L., Wu, T., Xu, L., Pan, X., & Liu, G. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583.pub3 · Cited by 7
Prevalence of Polycystic Ovary Syndrome in Iranian Adolescent Girls Based on Adults and Adolescents’ Diagnostic Criteria in Mashhad City
Pourhoseini, S. A., Babazadeh, R., & Mazloum, S. R. (2022) · Journal of Reproduction & Infertility · doi:10.18502/jri.v23i4.10815 · Cited by 6
Preincisional infiltration and intraperitoneal instillation of levobupivacaine 0.25% for management of early postoperative pain following laparoscopic ovarian drilling
Ismail, M. T., Hassanin, M. Z., & Elshmaa, N. S. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.01989.x · Cited by 6
Small glutamine-rich tetratricopeptide repeat–containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome
Butler, M. S., Yang, X., Ricciardelli, C., Liang, X., Norman, R. J., Tilley, W. D., & Hickey, T. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.140 · Cited by 6
Self-citation
Anti-Müllerian hormone in women with polycystic ovary syndrome
You, S.-Y., Park, S. Y., Yang, G. Y., Jeong, K. A., Kim, Y. J., & Chung, H. W. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.5.315 · Cited by 6
Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase‐2 in Women with Polycystic Ovary Syndrome
Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., França, J. B., Ferriani, R. A., & Tanus-Santos, J. E. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00895.x · Cited by 6
The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome
OKÇU, N. T., Nazik, H., Akduman, A. T., & Uncu, G. (2017) · The European Research Journal · doi:10.18621/eurj.332118 · Cited by 6
Effects of vitamin D supplementation on serum lipid profile in women with polycystic ovary syndrome
Shi, X., Yao, J., Fan, S., Hong, P.-P., Xia, Y., & Qiu, C. (2020) · Medicine · doi:10.1097/md.0000000000020621 · Cited by 6
Systematic oxidative stress is not associated with live birth rate in young non-obese patients with polycystic ovarian syndrome undergoing assisted reproduction cycles: A prospective cohort study
Chen, M., Huang, X. Y., Liu, Y., Lei, S., Wu, Y., Chen, Z., Hong, L., & Teng, X. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.07.049 · Cited by 6
Polycystic Ovary Syndrome in Women of Reproductive Age: Phenotypic Variety and Diagnostic Approaches. Review of Literature
Лазарева, Л. М., Russian Federation Irkutsk, Махарамович, Ш. Э., Васильевна, Б. Л., & Сутурина, Л. В. (2020) · Doctor Ru · doi:10.31550/1727-2378-2020-19-6-50-56 · Cited by 6
Novel Hub genes co-expression network mediates dysfunction in a model of polycystic ovary syndrome.
Xi, S., Li, W., Li, Z., Lin, W., Chen, L., Tian, C., Yang, Y., & Ma, L. (2022) · PubMed Central · Cited by 6
Association of FSHR and DENND1A polymorphisms with polycystic ovary syndrome: a meta-analysis
Larsen, C. B., Kúdela, E., & Biringer, K. (2022) · JBRA · doi:10.5935/1518-0557.20220043 · Cited by 6
Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
Plouvier, P., Peigné, M., Gronier, H., Robin, G., Catteau-Jonard, S., & Dewailly, D. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1145647 · Cited by 6
Self-citation
Le syndrome des ovaires polymicrokystiques – ou les follicules dans tous leurs excès
Robin, G., Catteau-Jonard, S., Dewailly, D., & Decanter, C. (2010) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2010.04.006 · Cited by 6
Self-citation
Reproductive Endocrinology and Infertility
Rebar, R. W., & Erickson, G. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00563-7 · Cited by 6
Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
Shah, D., & Jirge, P. R. (2024) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_153_23 · Cited by 5
Transcription repression of estrogen receptor alpha by ghrelin/Gq/11/YAP signaling in granulosa cells promotes polycystic ovary syndrome
Zhu, P., Bi, X., Su, D., Li, X., Chen, Y., Song, Z., Zhao, L., Wang, Y., Xu, S., & Wu, X. (2024) · Human Cell · doi:10.1007/s13577-024-01127-1 · Cited by 5
The relationship between prolactin and adipose tissue and metabolic parameters in patients with polycystic ovary syndrome
Aydın, G. A., & Özsoy, H. G. T. (2020) · The European Research Journal · doi:10.18621/eurj.668471 · Cited by 5
Overexpression of Pde4d in rat granulosa cells inhibits maturation and atresia of antral follicles to induce polycystic ovary
Jin, L., Yu, J., Xu, H., Chen, B., Yang, Q., Liu, Y., Guo, M., Zhou, C., Cheng, Y., Pang, H., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166869 · Cited by 5
Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
Butler, A. E., Brennan, E., Drage, D. S., Sathyapalan, T., & Atkin, S. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1270949 · Cited by 5
Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen
Liu, W., Tang, T., Feng, J., Wang, C., Lin, L., Wang, S., Zeng, K., Zou, R., Yang, Z., & Zhao, Y. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01361-z · Cited by 5
A Systemic Review of Pre-clinical Studies of Herbal Plants having Anti-Polycystic Ovarian Syndrome Activity: A PAN-India Study
Karmakar, M., Chakraborty, B., Hussain, A. S., Barbhuiya, P. A., Chang, N. Y., Warjri, I., Wankhar, W., Barman, U., Basak, M., Sen, S., et al. (2024) · The Natural Products Journal · doi:10.2174/0122103155303329240509115336 · Cited by 5
An association between fat mass and obesity–associated (FTO) (rs9939609) and kisspeptin-1 (KISS-1) (rs4889, rs372790354) gene polymorphisms with polycystic ovary syndrome: an updated meta-analysis and power analysis
Stephen, S. B., Pauline, R., Velmurugan, S., & Subbaraj, G. K. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03213-7 · Cited by 5
Verification of a ZBTB16 variant in polycystic ovary syndrome patients
Yang, J., Zhao, R., Li, L., Li, G., Yang, P., Ma, J., Zhao, S., & Zhao, H. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.05.005 · Cited by 5
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
Type and Frequency in Use of Nutraceutical and Micronutrient Supplementation for the Management of Polycystic Ovary Syndrome: A Systematic Scoping Review
Scannell, N., Mantzioris, E., Rao, V. S., Pandey, C., Ee, C., Mousa, A., Moran, L., & Villani, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11123349 · Cited by 5
Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
Yu, J., Moon, M. K., Ahn, H. C., & Yang, Y.-M. (2024) · Medicine · doi:10.1097/md.0000000000039055 · Cited by 6
Genetic and epigenetic correlation between diabetic retinopathy and polycystic ovarian syndrome: in-silico analyses-experimental research
Mirzaei, S., Darany, Z. S. S., Arjmand, N., Farhadi, B., Garrosi, L., & Najafi, A. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002970 · Cited by 5
Effect of combined oral contraceptive use on serum 25-hydroxy vitamin D levels and ultrasound parameters in patients with polycystic ovary syndrome
Kalem, M. N., Hızlı, D., Kamalak, Z., Köşüş, A., Köşüş, N., Turhan, N. Ö., & Kafalı, H. C. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1113251 · Cited by 5
Effects of Vitex agnus-castus extract on the secretory function of pituitary-gonadal axis and pregnancy rate in patients with premature ovarian aging (POA)
Rashidi, B. H., & Nemati, M. (2017) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2017.10.003 · Cited by 5
Comparison of In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycle Outcome in Patients with and without Polycystic Ovary Syndrome: A Modified Poisson Regression Model.
Almasi‐Hashiani, A., Mansournia, M. A., Sepidarkish, M., Vesali, S., Ghaheri, A., Esmailzadeh, A., & Samani, R. O. (2018) · PubMed Central · doi:10.22074/ijfs.2018.5117 · Cited by 5
The relationship between elevated serum xenin and insulin resistance in women with polycystic ovary syndrome: a case-control study
Güçlü, Y. A., Güleç, E. Ş., & Akşit, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1604663 · Cited by 6
Role for androgens in determination of ovarian fate in the common snapping turtle, Chelydra serpentina
Schroeder, A. L., & Rhen, T. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.05.003 · Cited by 5
Polycystic Ovary Syndrome (PCOS)
Hechtman, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00209-0 · Cited by 6
Effects of lisinopril treatment on the pathophysiology of PCOS and plasminogen activator inhibitor-1 concentrations in rats
Çoşkun, B., Ercan, C. M., Toğrul, C., Özhamam, E. U., Çoşkun, B., Eren, M., & Vaughan, D. E. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.09.011 · Cited by 5
A Comprehensive PCOS Research and Guideline Translation Program to Improve Practice
Ramasamy, V. A., Garad, R. M., & Boyle, J. A. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1733916 · Cited by 5
Genetic polymorphisms of reproductive hormones and their receptors in assisted reproduction technology for patients with polycystic ovary syndrome
Koloda, Y. A., Denisova, Y. V., & Podzolkova, N. M. (2021) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0123 · Cited by 5
Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS
Binder, A. K., Peecher, D. L., Qvigstad, A. J., Gutierrez, S. D., Magana, J., Banks, D. B., & Korach, K. S. (2023) · Endocrinology · doi:10.1210/endocr/bqad024 · Cited by 5
4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis
Wang, L., Wang, L., & Zhou, N. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3678-1 · Cited by 5
Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology
Alebić, M. Š., Stojanović, N., Baldani, D. P., & Duvnjak, L. S. (2016) · Endocrine · doi:10.1007/s12020-016-1062-y · Cited by 5
Polycystic Ovary Syndrome
Messinis, I. E., Messini, C. I., & Daponte, A. I. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108582322.015 · Cited by 5
Acne and Genetics
Melnik, B. C. (2014) · Springer eBooks · doi:10.1007/978-3-540-69375-8_14 · Cited by 5
Reproductive therapies and a need for potential biomarkers for prognostic and diagnostic screening of women desperate to conceive
Gadher, S. J., Jarkovská, K., & Kovářová, H. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.79 · Cited by 5
Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction?
Janci, M. M., Smith, R. C., & Odegard, P. S. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.229 · Cited by 5
What can we expect if we measure hormones in eumenorrhoeic infertile patients?
Nawroth, F., & Ludwig, M. Z. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60474-9 · Cited by 5
Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study.
Kahyaoğlu, S., Yumuşak, Ö. H., Ozyer, S. S., Pekcan, M. K., Erel, M., Çiçek, M. N., Erkaya, S., & Taşçı, Y. (2017) · PubMed Central · doi:10.22074/ijfs.2016.4849 · Cited by 5
Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance
Katsikis, I., Mouslech, T., Kourtis, A., Panidis, D., & Georgopoulos, N. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.075 · Cited by 5
Polycystic ovary syndrome: prognosis and risk of comorbidity
Hardy, T., Sousa, S. D., & Norman, R. J. (2013) · doi:10.2217/ebo.12.214 · Cited by 5
Self-citation
Evaluating spironolactone monotherapy against combined treatment with metformin in rat PCOS model
Bashir, S. M., Ali, S. I., Rather, M. A., Sheikh, W. M., Singh, H., Nabi, S. U., Ganie, M. A., Shafi, M., Shah, M. Z. U. H., Bhat, J. I., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177516 · Cited by 4
Female reproductive microbiome in fertility care
Dash, S., Zhao, D., Schuppe‐Koistinen, I., & Du, J. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.02.015 · Cited by 5
ASSESSMENT OF DMFT INDEXES, SALIVARY FLOW RATE, PH, AND DETECTIONS OF S.MUTANS SALIVARY LEVELS BY A QUANTITATIVE REAL-TIME PCR IN POLYCYSTIC OVARY SYNDROME
HİLALOĞLU, N. E. Y., & Sürmelioğlu, D. (2022) · Cumhuriyet Dental Journal · doi:10.7126/cumudj.1132273 · Cited by 4
Association of Vitamin D with Perfluorinated Alkyl Acids in Women with and without Non-Obese Polycystic Ovary Syndrome
Butler, A. E., Sathyapalan, T., Das, P., Brennan, E., & Atkin, S. L. (2024) · Biomedicines · doi:10.3390/biomedicines12061255 · Cited by 4
Exploring the regulatory mechanisms of reproductive dysfunction in obese patients with PCOS
Cui, J., Chang, H., Song, Y., Wang, H., & Sun, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-05454-7 · Cited by 4
Comprehensive Overview of PCOS: Exploring Etiology, Diagnosis, and Treatment Approaches
Singh, S. K., Gori, P., Patel, P., & Paul, A. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00419-w · Cited by 5
Up-regulated WNT5A in PCOS affects steroidogenesis, proliferation and apoptosis of granulosa cells through the PI3K/AKT pathway
Li, Y., Liu, Z., Tan, Y., Chen, Y., Huang, Z., & Chen, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01779-z · Cited by 5
The main directions and prospects in polycystic ovary syndrome treatment
Наримановна, У. А., Egorova, E. A., Yelisheva, E. A., Beitullaev, А. М., & Koryanova, K. N. (2021) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20210602 · Cited by 4
A study of retinal changes in women with polycystic ovarian syndrome
Shiromani, S., Bhatnagar, K., Singh, P., Suman, S., Meena, S., & Parveen, S. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_36_22 · Cited by 4

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks